Item 7.01 Regulation FD Disclosure.

On January 9, 2023, Quantum-Si Incorporated issued a press release announcing that it has begun commercial shipments of its Platinum™ protein sequencing system and revealed new partnerships, which the Company's management will discuss along with other business updates at the 41st Annual J.P. Morgan Healthcare Conference. A copy of the press release is furnished hereto as Exhibit 99.1.

The information in this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01. Financial Statements and Exhibits.





  (d) Exhibits.



  Exhibit
    No.                                  Description
    99.1     Press Release dated January 9, 2023.

    104      Cover Page Interactive Data File (embedded within the Inline XBRL
             document).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses